Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 1, 2005

Published online before print July 20, 2005
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0305158v1
78/4/937    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwak, S.-H.
Right arrow Articles by Abraham, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwak, S.-H.
Right arrow Articles by Abraham, E.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0305158


Received for publication March 18, 2005.
Revised May 26, 2005.
Accepted for publication June 11, 2005.


Article

The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins

Sang-Hyun Kwak *{dagger}, Sanchayita Mitra *, Khalil Bdeir {ddagger}, Derek Strassheim *, Jong Sung Park *, Jael Yeol Kim *{sect}, Steven Idell , Douglas Cines {ddagger}, and Edward Abraham *@

*Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver; {dagger}Department of Anesthesiology, Chonnam National University Medical School, Gwangju, Korea; {ddagger}Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; {sect}Department of Internal Medicine, Chung Ang University College of Medicine, Seoul, Korea; and Department of Specialty Care Services, The University of Texas Health Center at Tyler

@ To whom correspondence should be addressed. E-mail: edward.abraham{at}uchsc.edu.


   Abstract

Urokinase plasminogen activator (uPA) is a serine protease that catalyzes the conversion of plasminogen to plasmin. In addition, uPA has been shown to have proinflammatory properties, particularly in potentiating lipopolysaccharide (LPS)-induced neutrophil responses. To explore the mechanisms by which uPA exerts these effects, we examined the ability of specific uPA domains to increase cytokine expression in murine and human neutrophils stimulated with LPS. Whereas the addition of intact uPA to neutrophils cultured with LPS increased mRNA and protein levels of interleukin-1{beta}, macrophage-inflammatory protein-2, and tumor necrosis factor {alpha}, deletion of the kringle domain (KD) from uPA resulted in loss of these potentiating effects. Addition of purified uPA KD to LPS-stimulated neutrophils increased cytokine expression to a degree comparable with that produced by single-chain uPA. Inclusion of the arginine-glycine-aspartic but not the arginine-glycine-glutamic peptide to neutrophil cultures blocked uPA kringle-induced potentiation of proinflammatory responses, demonstrating that interactions between the KD and integrins were involved. Antibodies to {alpha}V or {beta}3 integrins or to the combination of {alpha}V{beta}3 prevented uPA kringle-induced enhancement of expression of proinflammatory cytokines and also of adhesion of neutrophils to the uPA KD. These results demonstrate that the KD of uPA, through interaction with {alpha}V{beta}3 integrins, potentiates neutrophil activation.

Key Words: uPA • IL-1{beta} • MIP-2 • TNF-{alpha} • growth factor domain




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. S. Lee, C. Moon, H. W. Lee, E.-M. Park, M.-S. Cho, and J. L. Kang
Src Tyrosine Kinases Mediate Activations of NF-{kappa}B and Integrin Signal during Lipopolysaccharide-Induced Acute Lung Injury
J. Immunol., November 15, 2007; 179(10): 7001 - 7011.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Tsuruta, Y.-J. Park, G. P. Siegal, G. Liu, and E. Abraham
Involvement of Vitronectin in Lipopolysaccaride-Induced Acute Lung Injury
J. Immunol., November 15, 2007; 179(10): 7079 - 7086.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. M. DiPasquale, M. Cheng, W. Billich, S. A. Huang, N. van Rooijen, T. A. Hornberger, and T. J. Koh
Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1278 - C1285.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Zhu, V. M. Gokhale, L. Szabo, R. M. Munoz, H. Baek, S. Bashyam, L. H. Hurley, D. D. Von Hoff, and H. Han
Identification of a novel inhibitor of urokinase-type plasminogen activator
Mol. Cancer Ther., April 1, 2007; 6(4): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Q. Wang, K. Bdeir, S. Yarovoi, D. B. Cines, W. Fang, and E. Abraham
Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury
J. Immunol., October 15, 2006; 177(8): 5550 - 5557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Society for Leukocyte Biology.